Literature DB >> 6697427

The carcinogenic potential of cytotoxic chemotherapy and its implications for therapeutic decision-making.

S K Carter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6697427     DOI： 10.1007/bf00254591

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  16 in total

1.  Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease.

Authors:  J Pedersen-Bjergaard; S O Larsen
Journal:  N Engl J Med       Date:  1982-10-14       Impact factor: 91.245

2.  The chemotherapy on plasma-cell myeloma and the incidence of acute leukemia.

Authors:  D E Bergsagel; A J Bailey; G R Langley; R N MacDonald; D F White; A B Miller
Journal:  N Engl J Med       Date:  1979-10-04       Impact factor: 91.245

Review 3.  The action of antitumor agents: a double-edged sword?

Authors:  S M Sieber
Journal:  Med Pediatr Oncol       Date:  1977

4.  Late effects of low-dose adjuvant chemotherapy in colorectal cancer.

Authors:  J D Boice; M H Greene; R J Keehn; G A Higgins; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1980-03       Impact factor: 13.506

5.  Second malignancies complicating Hodgkin's disease in remission.

Authors:  G P Canellos; J C Arseneau; V T DeVita; J Whang-Peng; R E Johnson
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321

6.  Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup.

Authors:  C A Coltman; D O Dixon
Journal:  Cancer Treat Rep       Date:  1982-04

7.  Late side effects of chemotherapy in ovarian carcinoma: a cytogenetic, hematologic, and statistical study.

Authors:  N Einhorn; G Eklund; S Franzén; B Lambert; J Lindsten; S Söderhäll
Journal:  Cancer       Date:  1982-06-01       Impact factor: 6.860

8.  Multimodal treatment in operable breast cancer: five-year results of the CMF programme.

Authors:  A Rossi; G Bonadonna; P Valagussa; U Veronesi
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-02

9.  Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU).

Authors:  J D Boice; M H Greene; J Y Killen; S S Ellenberg; R J Keehn; E McFadden; T T Chen; J F Fraumeni
Journal:  N Engl J Med       Date:  1983-11-03       Impact factor: 91.245

10.  Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials.

Authors:  M H Greene; J D Boice; B E Greer; J A Blessing; A J Dembo
Journal:  N Engl J Med       Date:  1982-12-02       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.